Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-18113-3.pdf
Reference44 articles.
1. Dreyer, C. et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68, 879–887 (1992).
2. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224–1234 (1994).
3. Lee, C. H., Olson, P. & Evans, R. M. Minireview: Lipid Metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 144, 2201–2207 (2003).
4. Barbier, O. et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 22, 717–726 (2002).
5. Issemann, I. & Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 346, 645–650 (1990).
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of mADM-collagen wound dressings for mimicking native skin architecture to enhance skin wound healing;Collagen and Leather;2024-07-01
2. Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases;Experimental Biology and Medicine;2024-06-27
3. Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy;Scientific Reports;2024-06-11
4. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway;J TRADIT CHIN MED;2024
5. Peroxisome proliferator‐activated receptors as therapeutic target for cancer;Journal of Cellular and Molecular Medicine;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3